Simple Education essential guides Intracoronary Guidance in Complex PCI is the premier international course focusing on intracoronary guidance of procedures during Complex PCI. The course is run by leading and world renowned international faculty. This course is specialising in the use of intracoronary guidance in complex PCI, and builds for the experienced coronary interventionist on 7 years of courses which have been run, and quickly established as the leading global interventional course in state-of-the-art coronary physiology and intracoronary imaging.
This Intracoronary Guidance in Complex PCI course provides all you need to know to understand about the use of intra coronary physiology and imaging to support complex PCI. The courses is composed of several session including multiple cases presentations, live cases, and interactive learning sessions.
Prof Javier Escaned is Head of Interventional Cardiology Section at Hospital Clinico San Carlos (Madrid, Spain). He trained as a cardiologist the United Kingdom before moving to the Thoraxcenter / Rotterdam (The Netherlands), where he obtained his PhD degree in 1994. A skilled interventionalist with over 25 years of experience, he regularly serves as live case operator and educationalist in global events like EuroPCR, TCT or the ESC Congress. He is author of over 350 PubMed indexed scientific articles (h-index 58) on topics that include complex PCI in multivessel disease (principal investigator of SYNTAX II study), left main and chronic total occlusions, and secondary revascularization. His track record in coronary physiology includes being investigator on pivotal FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR (since 2010), and developer of new methods for the assessment of microvascular and non-obstructive coronary disease. Recent / ongoing trials as Co-PI include ADVISE, ADVISE II, DEFINE FLAIR and ABSORB II PHYSIOLOGY, being investigator also in ILUMIEN I and IV, COMBINE and other studies on coronary imaging. Latest editorial contributions are the textbooks “Coronary Stenosis. Imaging, Structure and Physiology”, (co-editor Patrick Serruys) and “Physiological Assessment of Coronary Stenoses and the Microcirculation) (co-editor Justin Davies). Current or recent board positions in scientific societies include EuroPCR, EAPCI, EuroCTO and the ESC Working Group of Coronary Pathophysiology and Microcirculation. Some of his additional interests are philosophy, education and music.
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. Dr Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment. She designed, conducted and led the ORBITA trial and is the lead author of the primary publication in The Lancet. At Imperial College, she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Dr Al-Lamee has over 40 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She studied at the University of Oxford and University College London. She went onto complete her training as a junior doctor on the Barts and the London Medical rotation before being appointed as a Specialist Registrar on the North West London Cardiology rotation in 2006. Dr Al-Lamee has twelve years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.
Dr Nieves Gonzalo was born in Madrid, Spain in 1976. In 2006 she got the degree of Cardiologist after her training in Clinico San Carlos University Hospital in Madrid. After finishing her specialisation she moved to Rotterdam in The Netherlands for a research fellowship in the Thoraxcenter, Erasmus University with the team of Professor Patrick Serruys. There, she worked mainly in intracoronary imaging techniques and bioabsorbable stents. In 2010 she obtained her PhD with the thesis “Optical coherence tomography for the assessment of coronary atherosclerosis and vessel response after stent implantation”. Currently she works in the Interventional Cardiology Department at Clinico San Carlos University Hospital in Madrid.
Dr Colm Hanratty is a consultant cardiologist at Royal Victoria Hospital Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK which is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. The Belfast Trust is an acute infarct centre, tertiary referral centre and university teaching hospital.
Dr Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital, Roslyn, NY. He is also a member of the Cardiovascular Research Foundation, New York, NY where he currently serves as the Director of the Physiology Core Laboratory. He completed his Medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Centre, Harvard Medical School. Dr. Jeremias has numerous publications in the area of coronary physiology and intravascular imaging.
Dr Hernán Mejía-Rentería is Interventional Cardiologist at
Dr Dejan Milasinovic is an Intervention Cardiologist at Unit for Invasive Diagnostics and Interventional Cardiology, Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor/Teaching Assistant – Faculty of Medicine, University of Belgrade, Serbia. Dr Milasinovic as a local Sub-Investigator of these clinical trials: CONDI-2, COMPLETE, SHEAR-STENT, PzF SHIELD, APPOSITION V, MASTER-DAPT. |
 Prof Flavio Ribichini is Full Professor of Cardiovascular Medicine at the University of Verona and Chairman of the Cardiovascular Division at the University Hospital. He teaches at the School of Medicine of the Univeristy of Verona at different courses, and is the Director the School of Cardiology and the PhD School of Life and Health Sciences of the University of Verona with more than 60 fellows and PhD doctors. Member of the Task Force for Guidelines in Myocardial revascularization of the European Society of Cardiology. Member of the Editorial Board of the European Heart Journal. President of the Euro4C Group of PCR and Member of the PCR Scientific Program Committee. He is coordinator, Principal Investigator or member of the steering committees of several clinical trials and author of over 270 full publications on clinical and basic cardiovascular research in peer reviewed scientific journals available on PubMed. |
 Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial. |
 Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases.Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials. |
This essential guide is an educational activity intended for an international audience, specifically interventional cardiologists and cardiologists. However, other healthcare professionals involved in the care of coronary artery disease (CAD) patients will also find this topical.
This 2 day course general admission pass which covers registration, meals, and refreshments. After course free access to online course resources including powerpoint images, course videos, and links to other Simple Education resources.
Intracoronary Guidance in Complex PCI provides all you need to know to understand how to implement intracoronary guidance using physiology and imaging into complex PCI cases.
Dr Justin Davies is a consultant
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial
College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid
understanding of large artery physiology and to develop new
tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies). 
